Alten S.A. | Large-cap | Technology

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 3.5B
Total Liabilities 1.4B
Shareholders Equity 2.1B
Debt to Equity 0.65

Cash Flow Metrics

Revenue & Profitability Trend

Alten S.A Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i4.1B4.1B3.8B2.9B2.3B
Cost of Goods Sold i3.4B3.4B3.1B2.4B2.0B
Gross Profit i708.4M714.4M700.5M532.5M345.1M
Gross Margin % i17.1%17.6%18.5%18.2%14.8%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i---92.2M83.6M
Other Operating Expenses i208.9M214.0M180.7M123.7M38.1M
Total Operating Expenses i208.9M214.0M180.7M215.9M121.8M
Operating Income i354.5M351.2M392.9M298.5M132.2M
Operating Margin % i8.6%8.6%10.4%10.2%5.7%
Non-Operating Items
Interest Income i11.8M13.3M900.0K380.0K468.0K
Interest Expense i12.1M13.2M6.5M3.9M3.2M
Other Non-Operating Income-----
Pre-tax Income i280.4M320.1M595.0M286.5M133.3M
Income Tax i94.0M86.9M137.6M78.6M36.9M
Effective Tax Rate % i33.5%27.2%23.1%27.5%27.7%
Net Income i186.4M233.2M457.5M207.9M97.8M
Net Margin % i4.5%5.7%12.1%7.1%4.2%
Key Metrics
EBITDA i474.6M461.4M482.3M373.2M216.6M
EPS (Basic) i-€6.80€13.46€6.14€2.91
EPS (Diluted) i-€6.74€13.21€6.03€2.86
Basic Shares Outstanding i-34285278339837443385387633723333
Diluted Shares Outstanding i-34285278339837443385387633723333

Income Statement Trend

Alten S.A Balance Sheet From 2019 to 2023

Metric20232022202120202019
Assets
Current Assets
Cash & Equivalents i323.4M601.7M312.3M283.4M202.6M
Short-term Investments i-----
Accounts Receivable i1.0B964.1M778.8M586.6M693.6M
Inventory i-----
Other Current Assets225.2M122.2M103.4M80.1M68.4M
Total Current Assets i1.9B2.0B1.4B1.1B1.2B
Non-Current Assets
Property, Plant & Equipment i58.5M46.9M38.5M30.2M31.6M
Goodwill i2.3B2.0B1.8B1.4B1.1B
Intangible Assets i7.0M7.2M7.6M7.9M8.5M
Long-term Investments292.0K0---
Other Non-Current Assets1.0K----1.0K
Total Non-Current Assets i1.5B1.4B1.2B1.0B843.9M
Total Assets i3.4B3.4B2.6B2.2B2.1B
Liabilities
Current Liabilities
Accounts Payable i160.7M138.8M126.8M99.1M90.1M
Short-term Debt i170.0M57.5M52.0M44.1M42.8M
Current Portion of Long-term Debt-----
Other Current Liabilities51.5M568.9M442.7M344.6M367.3M
Total Current Liabilities i1.1B1.2B920.6M708.0M755.4M
Non-Current Liabilities
Long-term Debt i198.0M180.8M130.6M126.1M134.1M
Deferred Tax Liabilities i1.3M913.0K2.9M991.0K476.0K
Other Non-Current Liabilities851.0K92.8M120.2M70.3M18.2M
Total Non-Current Liabilities i236.6M303.1M287.8M231.5M181.4M
Total Liabilities i1.4B1.5B1.2B939.5M936.8M
Equity
Common Stock i36.9M36.3M36.1M36.0M35.9M
Retained Earnings i233.2M457.6M207.8M98.0M164.2M
Treasury Stock i9.0M9.7M---
Other Equity-----
Total Shareholders Equity i2.0B1.8B1.4B1.2B1.1B
Key Metrics
Total Debt i368.0M238.4M182.6M170.2M176.9M
Working Capital i778.1M749.1M529.0M429.6M450.8M

Balance Sheet Composition

Alten S.A Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i186.4M233.2M457.5M207.9M97.8M
Depreciation & Amortization i-----
Stock-Based Compensation i20.3M32.3M29.7M21.9M7.9M
Working Capital Changes i101.0M-94.3M-174.2M0169.8M
Operating Cash Flow i305.7M177.3M323.7M234.7M280.3M
Investing Activities
Capital Expenditures i648.0K352.0K---
Acquisitions i-311.3M-223.0M87.4M-104.5M-116.6M
Investment Purchases i-11.9M-96.3M-12.3M-3.2M-6.8M
Investment Sales i14.0M19.6M9.0M6.4M8.4M
Investing Cash Flow i-308.5M-299.3M84.2M-101.4M-231.6M
Financing Activities
Share Repurchases i---935.0K--356.0K
Dividends Paid i-52.1M-51.4M-44.4M-33.9M-
Debt Issuance i-----
Debt Repayment i-----
Financing Cash Flow i-65.0M-194.6M160.1M-27.5M-49.4M
Free Cash Flow i412.8M220.2M215.1M215.1M295.1M
Net Change in Cash i-67.7M-316.5M568.0M105.8M-692.0K

Cash Flow Trend

Alten S.A Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 12.26
Forward P/E 8.87
Price to Book 1.03
Price to Sales 0.55
PEG Ratio 8.87

Profitability Ratios

Profit Margin 4.50%
Operating Margin 9.26%
Return on Equity 8.78%
Return on Assets 6.29%

Financial Health

Current Ratio 1.52
Debt to Equity 16.78
Beta 1.30

Per Share Data

EPS (TTM) €5.32
Book Value per Share €63.50
Revenue per Share €119.29

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
ate2.3B12.261.038.78%4.50%16.78
Capgemini SE 21.7B13.731.8914.32%7.07%55.23
Sopra Steria 3.2B11.501.6014.37%4.76%63.80
Wavestone S.A 1.2B15.181.8112.60%8.01%12.75
Neurones S.A 992.4M18.992.5412.05%6.10%0.10
Atos SE 943.7M0.09-31.04%17.29%3.52

Financial data is updated regularly. All figures are in the company's reporting currency.